Dunedin Hospital is the main public hospital in Dunedin, New Zealand. It serves as the major base hospital for the Otago and Southland regions with a potential catchment radius of roughly 300 kilometres, and a population of around 300,000.

There are 400 (per 2015 audit) beds in Dunedin Hospital.

During the past decade, Dunedin Hospital conducted 58 clinical trials. In the 10-year time frame, 58 clinical trials started and 28 clinical trials were completed, i.e. on average, 48.3% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 21 clinical trials were completed. i.e. 80.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dunedin Hospital" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Boston Scientific Corporation" with 6 trials sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Shire" with 6 trials sponsored and "Trans Tasman Radiation Oncology Group" with 6 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dunedin Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 7 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 3 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 2 trials as a collaborator and "PharmaEssentia" with 2 trials as a collaborator. Other collaborators include 60 different institutions and companies that were collaborators in the rest 69 trials.

According to Clinical.Site data, the most researched conditions in "Dunedin Hospital" are "Coronary Artery Disease" (11 trials), "Ulcerative Colitis" (10 trials), "Crohn's Disease" (5 trials), "Asthma" (3 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Dunedin Hospital" in a lesser frequency.

Most popular intervention types in "Dunedin Hospital" are "Drug" (68 trials), "Device" (17 trials), "Other" (14 trials), "Biological" (6 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Etrolizumab" (4 trials), "Guselkumab" (4 trials), "Ontamalimab" (4 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Dunedin Hospital" are 91 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Dunedin Hospital". undefined are not yet recruiting, 19 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Dunedin Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Dunedin Hospital, 3 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".